BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 27098560)

  • 1. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
    Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
    J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
    Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
    J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus.
    Simpson N; Gatenby PA; Wilson A; Malik S; Fulcher DA; Tangye SG; Manku H; Vyse TJ; Roncador G; Huttley GA; Goodnow CC; Vinuesa CG; Cook MC
    Arthritis Rheum; 2010 Jan; 62(1):234-44. PubMed ID: 20039395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.
    Wen J; Chen CH; Stock A; Doerner J; Gulinello M; Putterman C
    Brain Behav Immun; 2016 May; 54():27-37. PubMed ID: 26721417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK as a target for therapy in systemic lupus erythematosus.
    Leng RX; Pan HF; Qin WZ; Wang C; Chen LL; Tao JH; Ye DQ
    Mol Biol Rep; 2011 Jan; 38(1):587-92. PubMed ID: 20358293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis.
    Chen J; Wei L; Xia Y
    Nephrology (Carlton); 2017 Feb; 22(2):101-106. PubMed ID: 27786399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C
    J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of TWEAK-Fn14 axis in lupus, a disease related to autoimmunity and fibrosis.
    Xu Y; Wei HT; Jing HY; Tan XY; Zhou XT; Ma YR
    Int J Rheum Dis; 2022 Jan; 25(1):21-26. PubMed ID: 34716660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
    Xu WD; Zhao Y; Liu Y
    Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the TWEAK/Fn14 pathway attenuates autoimmune arthritis in a SKG mouse model.
    Park JS; Kim SM; Jung KA; Lee J; Kwok SK; Cho ML; Park SH
    Histol Histopathol; 2017 May; 32(5):481-490. PubMed ID: 27653285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
    Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
    Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
    Izquierdo MC; Sanz AB; Mezzano S; Blanco J; Carrasco S; Sanchez-Niño MD; Benito-Martín A; Ruiz-Ortega M; Egido J; Ortiz A
    Kidney Int; 2012 Jun; 81(11):1098-107. PubMed ID: 22278019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.
    Liu ZC; Zhou QL
    Inflamm Res; 2012 Apr; 61(4):277-84. PubMed ID: 22297307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
    Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.
    Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C
    Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.